Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eliquis
Eliquis
Pharmaceuticals Swing; Teva, Pfizer, Bristol-Myers Moving Early
Barron's
Mon, 06/25/12 - 11:04 am
Teva Pharmaceuticals
Pfizer
Bristol-Myers Squibb
Eliquis
Copaxone
FDA delays decision again on Pfizer, Bristol-Myers anticlotting drug with information request
Yahoo/AP
Mon, 06/25/12 - 09:45 am
FDA
Pfizer
Bristol-Myers Squibb
Eliquis
German Panel Saw Little to No Added Benefit for Pfizer’s Eliquis
Bloomberg
Thu, 03/15/12 - 10:35 am
Pfizer
Germany
Eliquis
Bristol-Myers Squibb
FDA Delays Eliquis Verdict
Yahoo/Zacks
Sat, 03/3/12 - 11:39 am
Eliquis
Bristol-Myers Squibb
Pfizer
anti-clotting
Pfizer and Bristol-Myers’ Blood Thinner Delayed by FDA
Bloomberg
Thu, 03/1/12 - 10:48 am
Pfizer
bloodthinners
FDA
Eliquis
Bristol-Myers Squibb
Will FDA Delay Approving The Eliquis Bloodthinner?
Pharmalot
Wed, 02/29/12 - 11:08 am
FDA
bloodthinners
Eliquis
Replacing Coumadin: A $10 Billion Opportunity
Seeking Alpha
Mon, 02/13/12 - 07:58 pm
Coumadin
Eliquis
Pfizer
Apixaban
Bristol-Myers Squibb
Xarelto
Bayer
JNJ
Pradaxa
Boehringer Ingelheim
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Bristol-Pfizer drug gets FDA priority review
Reuters
Tue, 11/29/11 - 08:20 am
Pfizer
FDA
Bristol-Myers Squibb
anticlotting
Eliquis
Pfizer, Bristol-Myers’ Eliquis Recommended by U.K. Cost Agency
Bloomberg
Sat, 11/26/11 - 10:33 am
Pfizer
Bristol-Myers Squibb
Eliquis
anti-clotting
Quick review of Eliquis could lift Bristol, Pfizer
Reuters
Wed, 11/16/11 - 05:20 pm
Pfizer
Eliquis
Bristol-Myers Squibb
bloodthinner
Bristol, Pfizer clot drug fails to help ill patients
Reuters
Sun, 11/13/11 - 12:12 pm
Bristol-Myers Squibb
Pfizer
Eliquis
Apixaban
anticoagulants
Analyst Says Xarelto Niche "Still Secure"
Forbes
Mon, 08/29/11 - 10:57 am
Xarelto
bloodthinners
Bayer
JNJ
Pfizer
Bristol-Myers Squibb
Eliquis
Pfizer, Bristol-Myers May Lead $9B Stroke Market
Bloomberg
Mon, 08/29/11 - 10:56 am
stroke
bloodthinners
Pfizer
Eliquis
Bristol-Myers Squibb
ELIQUIS® (apixaban) was Superior to Warfarin for the Reduction of Stroke or Systemic Embolism with Significantly Less Major Bleeding in Patients with Atrial Fibrillation in Phase 3 ARISTOTLE Trial
Yahoo/BusinessWire
Sun, 08/28/11 - 12:22 pm
Eliquis
Apixaban
Warfarin
atrial fibrillation
stroke
Bristol-Myers Squibb
Pfizer
ARISTOTLE trial
Pfizer & Bristol-Myers to Release Highly Anticipated Data on Bloodthinner Hopeful
Motley Fool
Wed, 08/24/11 - 10:19 am
Pfizer
Bristol-Myers Squibb
Eliquis
bloodthinners
Apixaban
Data may prove Bristol, Pfizer drug a winner
Yahoo/Reuters
Mon, 08/22/11 - 11:40 am
Pfizer
stroke
Bristol-Myers Squibb
bloodthinners
Eliquis
Apixaban
Anti-Coagulant Blockbuster Drugs Are Here
Seeking Alpha
Mon, 07/25/11 - 09:08 am
anticlotting
blood thinners
JNJ
Pfizer
AstraZeneca
Bristol-Myers Squibb
Bayer
Xarelto
Pradaxa
Boehringer Ingelheim
Eliquis
Biotech Clinical Trials Update for 3 Drug Manufacturers
Seeking Alpha
Mon, 06/27/11 - 05:44 pm
Pfizer
Cel-Sci
Bristol-Myers Squibb
Eliquis
Multikine
EMA Recommends Approval for Pfizer, Bristol-Myers’ Eliquis
Bloomberg
Fri, 03/18/11 - 10:22 am
EMA
Europe
Eliquis
Pfizer
blood thinners
Apixaban
Pages
« first
‹ previous
1
2
3
4
5
6